Related Experiment Video
Updated: Jun 15, 2026
Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
Gene therapy in the Retinal Degeneration Slow model of retinitis pigmentosa
Xue Cai1, Shannon M Conley, Muna I Naash
1Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Abstract:
Human blinding disorders are often initiated by hereditary mutations that insult rod and/or cone photoreceptors and cause subsequent cellular death. Generally, the disease phenotype can be predicted from the specific mutation as many photoreceptor genes are specific to rods or cones; however certain genes, such as Retinal Degeneration Slow (RDS), are expressed in both cell types and cause different forms of retinal disease affecting rods, cones, or both photoreceptors. RDS is a transmembrane glycoprotein critical for photoreceptor outer segment disc morphogenesis, structural maintenance, and renewal. Studies using animal models with Rds mutations provide valuable insight into Rds gene function and regulation; and a better understanding of the physiology, pathology, and underlying degenerative mechanisms of inherited retinal disease. Furthermore, these models are an excellent tool in the process of developing therapeutic interventions for the treatment of inherited retinal degenerations. In this paper, we review these topics with particular focus on the use of rds models in gene therapy.
Insights
Animal models of Retinal Degeneration Slow (RDS) mutations offer insights into inherited retinal diseases. These models are crucial for understanding gene function and developing gene therapy for blinding disorders.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Hereditary mutations in photoreceptor genes cause human blinding disorders.
- Retinal Degeneration Slow (RDS) gene mutations affect both rods and cones, leading to diverse retinal diseases.
- RDS is vital for photoreceptor outer segment structure and maintenance.
Purpose of the Study:
- To review the function and regulation of the Rds gene.
- To explore the use of animal models in understanding inherited retinal degenerations.
- To focus on the application of RDS models in gene therapy development.
Main Methods:
- Review of existing literature on Rds gene function and mutations.
- Analysis of data from animal models with Rds mutations.
- Examination of studies utilizing RDS models for gene therapy research.
Main Results:
- Animal models with Rds mutations provide insights into gene function and disease mechanisms.
- Understanding Rds gene physiology and pathology is aided by these models.
- RDS models are instrumental in developing therapeutic strategies for retinal degenerations.
Conclusions:
- Animal models are essential for studying inherited retinal diseases caused by Rds mutations.
- RDS models are valuable tools for advancing gene therapy for blinding conditions.
- Further research using RDS models can accelerate the development of treatments for retinal degenerations.
Related Concept Videos
00:59Gene Therapy
01:22iPS Cell Differentiation